Informations générales (source: ClinicalTrials.gov)
HD-sEMG Markers of Sarcopenia
Interventional
N/A
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mai 2022
décembre 2026
09 mai 2026
Sarcopenia is a progressive and generalised skeletal muscle disorder involving the
accelerated loss of muscle mass and function that is associated with increased adverse
outcomes including falls, functional decline, frailty, and mortality.
In this pilot project, the investigators want to explore the potential of the
high-definition surface electromyography technology (HD-sEMG) for the diagnosis of
sarcopenia.
This is a monocentric, descriptive, cross-sectional, parallel group study to develop a
new diagnostic method.
It is planned to include 50 people aged 75 years and over hospitalized in the acute
geriatric ward and suspected of sarcopenia (Score ≥4 on the SARC-F screening
questionnaire).
The inclusion duration will be 36 months and adding a 1-month patient follow-up as part
of routine care, the total study duration will be 37 months.
Patients will have their body composition (muscle mass, fat mass, and bone mass) using
dual X-ray absorptiometry (DEXA). Muscular strength will be assessed by handgrip
strength. Physical performance will be assessed. Additional data will be collected from
their medical records.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP Assistance publique - Hôpitaux de Paris | 27/12/2025 07:36:35 | Contacter | |||
| AP-HP - Hôpital Charles Foix | |||||
| AP-HP - Hôpital Rothschild | |||||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CENTRE DE DEPISTAGE ET SOINS DE PARIS | Hester COLBOC, MD | Contact (sur clinicalTrials) | |||
| SOINS DE SUITE FONDATION ROTHSCHILD | Charlotte TOMEO, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Service de gériatrie aigue polyvalente (GAP) - 94205 - Ivry-sur-Seine - France | Alexandra Monti, Md | Contact (sur clinicalTrials) | |||
| Service de soins de suite et de réadaptation Gériatrique 1 - 94205 - Ivry-sur-Seine - France | Cristiano DONADIO, MD | Contact (sur clinicalTrials) | |||
| Service de soins de suite et de réadaptation gériatrique 2 - 94205 - Ivry-sur-Seine - France | Adeline GOURONNEC, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
- Patient aged 75 years and over
- Score ≥4 on the SARC-F screening questionnaire
- Enrolled in a social security plan (no AME)
- Informed and consenting patient
Exclusion Criteria:
- BMI ≥30 kg/m2
- Untreated/unbalanced endocrinological pathology
- Myopathy
- Inflammatory or autoimmune pathology
- Severe psychiatric pathology or severe cognitive disorders that do not allow the
performance of examinations
- Patients who are dependent for all acts of daily life
- Patients with a very short life expectancy
- Recent fracture or trauma of the lower limbs preventing dynamic measurement of
HD-sEMG recording
- Bilateral hip prosthesis
- Skin problem that may interfere with the recording of surface EMG activity
- Patient under guardianship / curatorship